[MIRM] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[MIRM] Mirum Pharmaceuticals, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 68.14%
YoY- 33.94%
Quarter Report
MIRM's Result
MIRM's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 77,875 69,222 69,554 47,725 37,497 31,598 27,906 98.33%
PBT -24,003 -24,655 -32,924 -23,339 -73,722 -29,929 -36,291 -24.10%
Tax 635 624 225 249 316 201 140 174.26%
NP -24,638 -25,279 -33,149 -23,588 -74,038 -30,130 -36,431 -22.97%
Tax Rate - - - - - - - -
Total Cost 102,513 94,501 102,703 71,313 111,535 61,728 64,337 36.45%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -31.64 -36.52 -47.66 -49.42 -197.45 -95.35 -130.55 -61.16%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.52 -0.54 -0.71 -0.57 -1.94 -0.80 -0.99 -34.92%
EPS Diluted -0.52 -0.54 -0.71 -0.57 -1.94 -0.80 -0.97 -34.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.